Target intelligence / Profile preview

Nicotinic acetylcholine receptor adult muscle-type (α1)_2β1δε (nAChR (adult muscle-type))

Target
nAChR (adult muscle-type)
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor, Receptor
01

Overview

The nicotinic acetylcholine receptor adult muscle-type (α1)_2β1δε is a ligand-gated ion channel located at the postsynaptic membrane of the neuromuscular junction in skeletal muscle.[3][4][5] It is a heteropentameric protein complex composed of five subunits: two alpha-1 (α1), one beta-1 (β1), one delta (δ), and one epsilon (ε), with the ε subunit replacing the γ subunit in adult muscle ("fetal" and "adult" forms).[3][4] Upon binding of acetylcholine, the conformational change in the receptor opens its central pore, allowing sodium and potassium ions to cross the membrane, which triggers muscle contraction. The receptor is essential for normal neuromuscular function and is a major target for muscle relaxants (used in anesthesia and intensive care), as well as autoantibodies in myasthenia gravis.[3][4][5]

Other names
muscle nicotinic acetylcholine receptoradult muscle nAChR(α1)_2β1δε receptoradult neuromuscular nAChR
02

Mechanism of action

Agonists bind and activate the receptor to open the ion channel, leading to depolarization (e.g., acetylcholine, nicotine). Antagonists block acetylcholine binding or channel opening (e.g., tubocurarine, pancuronium, α-bungarotoxin). Depolarizing blockers cause prolonged activation leading to desensitization (e.g., succinylcholine).

03

Biological functions

Signal transductionNeuromuscular transmissionSynaptic transmissionMuscle contraction
04

Disease associations

Neuromuscular diseaseCongenital myasthenic syndromesAutoimmune myasthenia gravisOther (disorders of neuromuscular junction)
05

Safety considerations

Risk of prolonged paralysis and apnea when blockedAutoimmune adverse reactionsResistance or hypersensitivity in congenital syndromes
06

Interacting drugs

Succinylcholine

6 more in the full profile.

07

Biomarkers

Autoantibodies against nAChR (biomarker for myasthenia gravis)

Beyond the preview

Go deeper on Nicotinic acetylcholine receptor adult muscle-type (α1)_2β1δε (nAChR (adult muscle-type)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic acetylcholine receptor adult muscle-type (α1)_2β1δε (nAChR (adult muscle-type)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call